Daratumumab, Bortezomib, and Dexamethasone With or Without Venetoclax in Treating Patients With Relapsed or Refractory Multiple Myeloma

Name: Daratumumab, Bortezomib, and Dexamethasone With or Without Venetoclax in Treating Patients With Relapsed or Refractory Multiple Myeloma
License: Public Domain

National Cancer Institute (NCI)

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

recurrent plasma cell myeloma, refractory plasma cell myeloma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 127570
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.